Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering Of 1.225M Units Of Common Stock, Warrants At $8.125/Unit
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while
